Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
alpha-1,3-glucan is a critical exopolysaccharide component of the extracellular polymeric substance (EPS) matrix in bacterial biofilms, most notably in dental plaque formed by Streptococcus mutans [2, 10]. Synthesized from dietary sucrose by extracellular glucosyltransferases, this water-insoluble polymer provides the essential structural framework and adhesive properties required for biofilm stability and attachment to tooth surfaces [7, 13]. Beyond its structural role, alpha-1,3-glucan acts as a protective barrier that sequesters antimicrobial agents and shields bacteria from host immune responses, contributing significantly to the high antibiotic resistance observed in biofilm-associated infections [8, 15]. In the context of oral health, the accumulation of alpha-1,3-glucan facilitates the localized production of organic acids, leading to enamel demineralization and the development of dental caries [4, 17]. Therapeutic strategies targeting this molecule involve the use of glucanohydrolases, such as mutanase (alpha-1,3-glucanase), which enzymatically hydrolyze the alpha-1,3-glycosidic bonds to destabilize the biofilm architecture [5, 11]. This non-biocidal approach promotes biofilm dispersal and enhances the efficacy of co-administered antimicrobial agents without indiscriminately killing the commensal oral microbiota [2, 3].
Enzymatic hydrolysis of alpha-1,3-glycosidic bonds leading to biofilm matrix degradation and dispersal
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on alpha-1,3-glucan.